期刊
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT
卷 23, 期 -, 页码 210-224出版社
CELL PRESS
DOI: 10.1016/j.omtm.2021.09.006
关键词
-
资金
- European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [715571]
- Scientific Service Units (SSU) of IST Austria
- European Research Council (ERC) [715571] Funding Source: European Research Council (ERC)
This study demonstrates that modifying the AAV6 capsid can enhance microglial transduction in the outer plexiform layer, validated in the retina as a model system, and highlights the significant influence of environmental conditions on microglial transduction efficiency.
Adeno-associated viruses (AAVs) are widely used to deliver genetic material in vivo to distinct cell types such as neurons or glial cells, allowing for targeted manipulation. Transduction of microglia is mostly excluded from this strategy, likely due to the cells' heterogeneous state upon environmental changes, which makes AAV design challenging. Here, we established the retina as a model system for microglial AAV validation and optimization. First, we show that AAV2/6 transduced microglia in both synaptic layers, where layer preference corresponds to the intravitreal or subretinal delivery method. Surprisingly, we observed significantly enhanced microglial transduction during photoreceptor degeneration. Thus, we modified the AAV6 capsid to reduce heparin binding by introducing four point mutations (K531E, R576Q, K493S, and K459S), resulting in increased microglial transduction in the outer plexiform layer. Finally, to improve microglial-specific transduction, we validated a Cre-dependent transgene delivery cassette for use in combination with the Cx3cr1(CreERT2) mouse line. Together, our results provide a foundation for future studies optimizing AAV-mediated microglia transduction and highlight that environmental conditions influence microglial transduction efficiency.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据